Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: A randomized placebo-controlled study

Critical Care Medicine

Volumn 41, Issue 10, 2013, Pages 2328-2335

  Bragadottir, Gudrun ^a   Redfors, Bengt ^a   Ricksten, Sven Erik ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cardiac surgery; glomerular filtration rate; levosimendan; renal blood flow; renal oxygen consumption; renal oxygenation

Indexed keywords

EDETATE CHROMIUM CR 51; LEVOSIMENDAN; PLACEBO; PROPOFOL;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD OXYGENATION; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CRYSTALLOID; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART INDEX; HEART RATE; HEART STROKE VOLUME; HEART SURGERY; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE UNIT; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; LOADING DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; OXYGEN SUPPLY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SURGICAL PATIENT; SYSTEMIC VASCULAR RESISTANCE; TERTIARY HEALTH CARE; THERMODILUTION;

AGED; CARDIAC OUTPUT; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PYRIDAZINES; RENAL CIRCULATION; SWEDEN; THORACIC SURGICAL PROCEDURES;

EID: 84884907947     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31828e946a     Document Type: Article

References (37)

1. Mangano CM, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128:194-203 (Pubitemid 28078200)
2. Heringlake M, Knappe M, Vargas Hein O, et al: Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol 2006; 72:645-654 (Pubitemid 44251570)
3. Robert AM, Kramer RS, Dacey LJ, et al; Northern New England Cardiovascular Disease Study Group: Cardiac surgery-associated acute kidney injury: A comparison of two consensus criteria. Ann Thorac Surg 2010; 90:1939-1943
4. Englberger L, Suri RM, Li Z, et al: Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011; 15:R16
5. Mehta RL, Kellum JA, Shah SV, et al; Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
6. Lassnigg A, Schmidlin D, Mouhieddine M, et al: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol 2004; 15:1597-1605 (Pubitemid 38679685)
7. Kanji HD, Schulze CJ, Hervas-Malo M, et al: Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg 2010; 5:71
8. Habib RH, Zacharias A, Schwann TA, et al: Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 2005; 33:1749-1756 (Pubitemid 41153700)
9. Swaminathan M, Phillips-Bute BG, Conlon PJ, et al: The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76:784-791 (Pubitemid 37100744)
10. Brezis M, Rosen S: Hypoxia of the renal medulla-Its implications for disease. N Engl J Med 1995; 332:647-655
11. Block CA, Manning HL: Prevention of acute renal failure in the critically ill. Am J Respir Crit Care Med 2002; 165:320-324 (Pubitemid 34118501)
12. Swärd K, Valsson F, Sellgren J, et al: Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005; 31:79-85 (Pubitemid 40174285)
13. Redfors B, Swärd K, Sellgren J, et al: Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 2009; 35:115-122
14. Bragadottir G, Redfors B, Nygren A, et al: Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand 2009; 53:1052-1059
15. Redfors B, Bragadottir G, Sellgren J, et al: Acute renal failure is NOT an "acute renal success"-A clinical study on the renal oxygen supply/ demand relationship in acute kidney injury. Crit Care Med 2010; 38:1695-1701
16. Redfors B, Bragadottir G, Sellgren J, et al: Dopamine increases renal oxygenation: A clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand 2010; 54:183-190
17. Salmenperä M, Eriksson H: Levosimendan in perioperative and critical care patients. Curr Opin Anaesthesiol 2009; 22:496-501
18. Mebazaa A, Pitsis AA, Rudiger A, et al: Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010; 14:201
19. Lahtinen P, Pitkänen O, Pölönen P, et al: Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebocontrolled trial. Crit Care Med 2011; 39:2263-2270
20. Lehmann A, Boldt J, Kirchner J: The role of Ca++-sensitizers for the treatment of heart failure. Curr Opin Crit Care 2003; 9:337-344 (Pubitemid 37204787)
21. McBride BF, White CM: Levosimendan: Implications for clinicians. J Clin Pharmacol 2003; 43:1071-1081 (Pubitemid 37174438)
22. Swärd K, Valsson F, Sellgren J, et al: Bedside estimation of absolute renal blood flow and glomerular filtration rate in the intensive care unit. A validation of two independent methods. Intensive Care Med 2004; 30:1776-1782 (Pubitemid 39297182)
23. Tidgren B, Brodin U: Plasma renin activity and oxygen content along the renal veins in hypertensive patients. Clin Physiol 1988; 8:407-416
24. Andersson LG, Bratteby LE, Ekroth R, et al: Calculation of renal extraction during high diuresis and low renal plasma flow conditions. Clin Physiol 1994; 14:79-85 (Pubitemid 24030644)
25. Pagel PS, Hettrick DA, Warltier DC: Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol 1996; 119:609-615 (Pubitemid 26335328)
26. Oldner A, Konrad D, Weitzberg E, et al: Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 2001; 29:2185-2193 (Pubitemid 33063549)
27. Faivre V, Kaskos H, Callebert J, et al: Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharidetreated rabbits. Anesthesiology 2005; 103:514-521 (Pubitemid 41243413)
28. Yilmaz MB, Yalta K, Yontar C, et al: Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine. Cardiovasc Drugs Ther 2007; 21:431-435 (Pubitemid 350231513)
29. Zemljic G, Bunc M, Yazdanbakhsh AP, et al: Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation. J Card Fail 2007; 13:417-421 (Pubitemid 47176926)
30. Follath F, Cleland JG, Just H, et al; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002; 360:196-202 (Pubitemid 34804646)
31. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356:2139-2143 (Pubitemid 32047951)
32. Valsson F, Ricksten SE, Hedner T, et al: Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996; 22:230-236 (Pubitemid 26093273)
33. Swärd K, Valsson F, Odencrants P, et al: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo- controlled trial. Crit Care Med 2004; 32:1310-1315 (Pubitemid 38738585)
34. Kiil F, Aukland K, Refsum HE: Renal sodium transport and oxygen consumption. Am J Physiol 1961; 201:511-516
35. Damman K, Navis G, Smilde TD, et al: Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007; 9:872-878 (Pubitemid 47332311)
36. Damman K, Voors AA: Levosimendan improves renal function in acute decompensated heart failure: Cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine by Yilmaz et al.". Cardiovasc Drugs Ther 2007; 21:403-404 (Pubitemid 50004695)
37. Morelli A, De Castro S, Teboul JL, et al: Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005; 31:638-644 (Pubitemid 40684980)